Literature DB >> 8783472

Headache-free controls? Evidence of headaches in individuals who deny having headaches during diagnostic screening.

D A Wittrock1, S K Ficek, T M Cook.   

Abstract

In the course of two studies investigating whether individuals with recurrent tension headache differ from headache-free controls in the frequency and appraisal of stressful life events, subjects were asked to complete a headache diary for 1 week. Subjects in the headache-free control group were screened twice and reported having infrequent headaches (two or less per month). However, 13 of 38 control subjects reported multiple headache days on their headache diaries. These subjects also reported a greater frequency of stressful events and a greater stress impact score. These results suggest that a careful screening of control subjects may be necessary in studies that examine differences between subjects with recurrent headache and headache-free controls. There is also some evidence that the inclusion of these subjects in a control group may bias the sample, making it less likely to find between-group differences.

Entities:  

Mesh:

Year:  1996        PMID: 8783472     DOI: 10.1046/j.1526-4610.1996.3607416.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

Review 1.  Behavioral treatment of migraine in children and adolescents.

Authors:  Robert J Baumann
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Appraisal of subjective stress in individuals with tension-type headache: the influence of baseline measures.

Authors:  T C Myers; D A Wittrock; G W Foreman
Journal:  J Behav Med       Date:  1998-10

3.  Validation of a Georgian language headache questionnaire in a population-based sample.

Authors:  Maka Kukava; Anna Dzagnidze; Marina Janelidze; Eka Mirvelashvili; Mamuka Djibuti; Guenther Fritsche; Rigmor Jensen; Lars J Stovner; Timothy J Steiner; Zaza Katsarava
Journal:  J Headache Pain       Date:  2007-12-10       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.